Form D · Biotechnology
BobcatBio, Inc.
Hummelstown, PA · CIK 0001876657
Offering snapshot reported Mar 12, 2025 · SEC filing
- Reported sold
- $5.34M Offering amount: $15M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 26, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 12, 2025 | Initial | $5,340,751 | No comparison | 11 | SEC filing |
| Jan 22, 2024 | Amendment | $27,099,514 | $14,058,684vs Nov 18, 2022 | 10 | SEC filing |
| Nov 18, 2022 | Amendment | $13,040,830 | $6,819,799vs Aug 5, 2021 | 10 | SEC filing |
| Aug 5, 2021 | Initial | $6,221,031 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-540640
Source: Form D, filed Mar 12, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Fucci | Director |
| Rifat Pamukcu | Director |
| Stephen C. Rocamboli | Director, Executive |
| Roger Sawhney | Director |
| Robert Towarnicki | Director |
| Tim Van Treuren | Director |
| Travis Whitfill | Director |
| Travis Whitfull | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1214 Research Boulevard, Suite 2010
Hummelstown, PA, 17036
Hummelstown, PA, 17036